scispace - formally typeset
G

Guang Hua Xu

Researcher at Yanbian University

Publications -  25
Citations -  761

Guang Hua Xu is an academic researcher from Yanbian University. The author has contributed to research in topics: PI3K/AKT/mTOR pathway & NF-κB. The author has an hindex of 12, co-authored 25 publications receiving 417 citations.

Papers
More filters
Journal ArticleDOI

Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.

TL;DR: It is suggested that imperatorin is an effective inhibitor of HIF-1 and provide new perspectives into the mechanism of its anticancer activity.
Journal ArticleDOI

Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways.

TL;DR: The anti-inflammatory effects of artemisinin in TPA-induced skin inflammation in mice were demonstrated and it was proved that art Artemisinin potentiated TNF-α-induced apoptosis.
Journal ArticleDOI

Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1α and STAT3 in human colon cancer cells

TL;DR: Investigation of the potential activity of panaxadiol on programmed cell death-ligand 1 (PD-L1) expression and tumour proliferation in human colon cancer cells and the underlying mechanism revealed insights into development of cancer therapeutic through PD-L 1 inhibition.
Journal ArticleDOI

Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.

TL;DR: The result of the current study show that convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/ STAT3 (S727) signaling pathways in colorectal cancer cells and indicate that conv allatoxin could be a valuable candidate for the development of coloreCTal cancer therapeutic.
Journal ArticleDOI

Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer

TL;DR: Results illustrated that curcumol inhibits the expression of PD-L1 through crosstalk between HIF-1α and p-STAT3 (T705) signaling pathways in hepatic cancer, and might represent a promising lead compound for the development of new targeted anti-cancer therapeutics.